Company: APM
Filing Date: 2025-10-06
Form Type: S-4
Source: 0001213900-25-096656
Chunk: 58

Company: Aptorum Group Ltd
Filing Date: 2025-10-06
Form: S-4
Chunk 58
---
, the interests of Aptorum shareholders; •if Aptorum’s due diligence investigation of DiamiR was inadequate or if unexpected risks related to DiamiR’s business materialize, it could have a material adverse effect on the investment of Aptorum’s shareholders; •after the completion of the Merger, the Combined Company may fail to realize the anticipated benefits and cost savings of the Merger, which could adversely affect the value of the shares of Combined Company common stock following the Merger; •upon the completion of the Merger, Aptorum shareholders will have different rights under the Combined Company’s governing documents from those they currently have under Aptorum’s governing documents; •current Aptorum shareholders will have a reduced ownership and voting interest after the Merger and will exercise less influence over the management of the Combined Company; •the future results of the Combined Company may be adversely impacted if the Combined Company does not effectively manage its expanded operations following completion of the Merger; •each of Aptorum and DiamiR expects to incur substantial expenses related to the completion of the Merger and the integration of the businesses of Aptorum and DiamiR; and •the market price of shares of Combined Company common stock after the Merger may be affected by factors different from those that are currently affecting or historically have affected the market price of shares of Aptorum Class A ordinary shares. Consequently, all of the forward -lookingstatements Aptorum or DiamiR made in this document are qualified by the information contained in or incorporated by reference into this proxy statement/prospectus, including, but not limited to, (i) the information contained under this heading, (ii) the information discussed in the section of this proxy statement/prospectus entitled “Risk Factors” and (iii) the information discussed under the section entitled “Risk Factors” in Aptorum’s 2024 Form 20 -Fand subsequent filings by Aptorum with the SEC. For more information, please see the section of this proxy statement/prospectus entitled “Where You Can Find More Information.” Neither Aptorum nor DiamiR is under any obligation, and each expressly disclaims any obligation, to update, alter or otherwise revise any forward -lookingstatements, whether written or oral, that may be made from time to time, whether as a result of new information, future events or otherwise, except as required by law. Persons reading this proxy statement/prospectus are cautioned not to place undue reliance on these forward -lookingstatements, which speak only as of the date hereof. 14 R